Sign in
Taking peopleNo phase

The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements

Key facts

Who runs it
University of Sheffield
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
25 Nov 2025
Expected to end
Jun 2027
Type of study
Interventional, 6 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 5-hydroxytryptophan (food supplement) 200mg
  • 5-hydroxytryptophan (food supplement) 300mg
  • Placebo
Record updated
20 August 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • 18-65 years of age
  • Normal or corrected to normal vision with contact lenses
  • Score of <9 or >14 on the ASRS v5 (assessed in pre screen questionnaire)

Who cannot take part

  • Current use of psychostimulant medication or medication for the treatment of ADHD
  • Current use of medications known to impact the serotonergic system (e.g., SSRIs)
  • Smoking or vaping
  • Pregnancy
  • Breast feeding
  • Lactose intolerance
  • Veganism
  • Dyslexia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this project is to look at the impact of 5-Hydroxytryptophan (5-HTP) on distractibility. 5-HTP is the precursor to the neurotransmitter serotonin and is a chemical that the body produces naturally. There is evidence that distractibility is associated with a decreased level of serotonin. This research aims to see if giving people 5-HTP will alter their distractibility, which will form part of an initial assessment as to whether 5-HTP could be used to support people with attention problems. The study involves completing a short survey about mental health and behaviours, and if eligible, participation in an in-person study at the University of Sheffield. The in-person session involves completing some cognitive tasks to look at eye movement, taking 5-HTP or a sugar tablet with no active ingredients, and then completing the tasks again after a 90-minute wait.

The 6 groups in the trial

  • High ADHD traits - 200mg 5-HTPTreatment being tested

    Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving 200 mg 5-HTP, administered orally in tablet form.

    Treatment: 5-hydroxytryptophan (food supplement) 200mg

  • High ADHD traits - 300mg 5-HTPTreatment being tested

    Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving 300 mg 5-HTP, administered orally in tablet form.

    Treatment: 5-hydroxytryptophan (food supplement) 300mg

  • High ADHD traits - PlaceboPlacebo, for comparison

    Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving placebo. Placebo consists of 2 sucrose-lactose tablets, administered orally.

    Treatment: Placebo

  • Low ADHD traits - 200mg 5-HTPExisting treatment, for comparison

    Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving 200 mg 5-HTP, administered orally in tablet form.

    Treatment: 5-hydroxytryptophan (food supplement) 200mg

  • Low ADHD traits - 300mg 5-HTPExisting treatment, for comparison

    Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving 300 mg 5-HTP, administered orally in tablet form.

    Treatment: 5-hydroxytryptophan (food supplement) 300mg

  • Low ADHD traits - placeboPlacebo, for comparison

    Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving placebo. Placebo consists of 2 sucrose-lactose tablets, administered orally.

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of 5-hydroxytryptophan on Microsaccades and Distractibility in Individual With High Levels of ADHD Traits: a Randomised, Double-blind Trial
Fit questions
Built from NCT07777328, who can take part
Record updated
20 August 2026